Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
New Study Confirms 340B Program is Exploited
A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.
Salvage the Good from the Healthcare Debacle
The healthcare reform juggernaut, arguably the most radical attempt to remake the economy and the nation’s healthcare infrastructure in history, was supposed to have flown through Congress before the August recess with nary a peep. Instead, as Americans have gotten wind of its alarming provisions and exorbitant costs, the plan appears to be fizzling fast in the summer heat.